Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Moeller

Showing results (81-90 of 90) with videos related to

Pageof 9
Sort By:
You have reached the last page of results.This site can display upto 90 results.
Drug and Alcohol Dependence|March 14, 1997
Antisocial personality disorder and aggression in recently abstinent cocaine dependent subjectsF G Moeller, D M Dougherty, T Rustin, et al.
Psychoneuroendocrinology|June 7, 2000
Low dose zolmitriptan as a 5-HT neuroendocrine challenge agent in humansF G Moeller, J M Bjork, D M Dougherty, et al.
Pharmacogenetics and Genomics|May 10, 2014
The influence of dopamine β-hydroxylase gene polymorphism rs1611115 on levodopa/carbidopa treatment for cocaine dependence: a preliminary studyShijing Liu, Charles E Green, Scott D Lane, et al.
Behavioural Pharmacology|April 19, 2011
Serotonin (5-hydroxytryptamine) 5-HT(2A) receptor: association with inherent and cocaine-evoked behavioral disinhibition in ratsNoelle C Anastasio, Erin C Stoffel, Robert G Fox, et al.
International Journal of Clinical Pharmacology and Therapeutics|December 31, 2002
Results of phase I pharmacokinetic and pharmacodynamic studies of the Raf kinase inhibitor BAY 43-9006 in patients with solid tumorsD Strumberg, D Voliotis, J G Moeller, et al.
Psychiatry Research. Neuroimaging|June 29, 2020
Examination of preliminary behavioral and effective connectivity findings from treatment response to citalopram in cocaine use disorder: A dynamic causal modeling studyA D Snyder, E Zuniga, L Ma, et al.
International Journal of Clinical Pharmacology and Therapeutics|December 31, 2002
ERK1/2 phosphorylation: a biomarker analysis within a phase I study with the new Raf kinase inhibitor BAY43-9006R A Hilger, S Kredke, D Hedley, et al.
The American Journal of Drug and Alcohol Abuse|March 27, 2009
Evaluation of heterogeneity in pharmacotherapy trials for drug dependence: a Bayesian approachC E Green, F G Moeller, J M Schmitz, et al.
Biological Psychiatry|March 1, 1996
Impulsivity and neuroendocrine response to buspirone in bulimia nervosaD A Waller, A l Sheinberg, C Gullion, et al.
Translational Psychiatry|March 13, 2014
Variation within the serotonin (5-HT) 5-HT₂C receptor system aligns with vulnerability to cocaine cue reactivityN C Anastasio, S Liu, L Maili, et al.
Pageof 9

Showing results (81-90 of 90) with videos related to

Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 90 results.
Drug and Alcohol Dependence|March 14, 1997
Antisocial personality disorder and aggression in recently abstinent cocaine dependent subjectsF G Moeller, D M Dougherty, T Rustin, et al.
Psychoneuroendocrinology|June 7, 2000
Low dose zolmitriptan as a 5-HT neuroendocrine challenge agent in humansF G Moeller, J M Bjork, D M Dougherty, et al.
Pharmacogenetics and Genomics|May 10, 2014
The influence of dopamine β-hydroxylase gene polymorphism rs1611115 on levodopa/carbidopa treatment for cocaine dependence: a preliminary studyShijing Liu, Charles E Green, Scott D Lane, et al.
Behavioural Pharmacology|April 19, 2011
Serotonin (5-hydroxytryptamine) 5-HT(2A) receptor: association with inherent and cocaine-evoked behavioral disinhibition in ratsNoelle C Anastasio, Erin C Stoffel, Robert G Fox, et al.
International Journal of Clinical Pharmacology and Therapeutics|December 31, 2002
Results of phase I pharmacokinetic and pharmacodynamic studies of the Raf kinase inhibitor BAY 43-9006 in patients with solid tumorsD Strumberg, D Voliotis, J G Moeller, et al.
Psychiatry Research. Neuroimaging|June 29, 2020
Examination of preliminary behavioral and effective connectivity findings from treatment response to citalopram in cocaine use disorder: A dynamic causal modeling studyA D Snyder, E Zuniga, L Ma, et al.
International Journal of Clinical Pharmacology and Therapeutics|December 31, 2002
ERK1/2 phosphorylation: a biomarker analysis within a phase I study with the new Raf kinase inhibitor BAY43-9006R A Hilger, S Kredke, D Hedley, et al.
The American Journal of Drug and Alcohol Abuse|March 27, 2009
Evaluation of heterogeneity in pharmacotherapy trials for drug dependence: a Bayesian approachC E Green, F G Moeller, J M Schmitz, et al.
Biological Psychiatry|March 1, 1996
Impulsivity and neuroendocrine response to buspirone in bulimia nervosaD A Waller, A l Sheinberg, C Gullion, et al.
Translational Psychiatry|March 13, 2014
Variation within the serotonin (5-HT) 5-HT₂C receptor system aligns with vulnerability to cocaine cue reactivityN C Anastasio, S Liu, L Maili, et al.
Pageof 9